Who has invested in iECURE?

Versant Ventures, OrbiMed Advisors are named among the investors backing iECURE.

iECURE Funding: $50M Raised, Series A (2021)

iECURE funding overview

iECURE is a Biotech company based in Philadelphia, Pennsylvania. iECURE has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for iECURE runs through 2021; nothing later has been disclosed. Investors on record include Versant Ventures, OrbiMed Advisors. 2 distinct backers are named across the disclosed rounds.

iECURE at a glance

Total raised: $50M
Latest round: Series A
Latest round date: September 2021
Industry: Biotech
Headquarters: Philadelphia, Pennsylvania
Notable investors: Versant Ventures, OrbiMed Advisors

Frequently asked about iECURE funding

How much has iECURE raised?: iECURE has raised $50M in total disclosed funding across the rounds on record.
Who has invested in iECURE?: Versant Ventures, OrbiMed Advisors are named among the investors backing iECURE.
What was the latest iECURE funding round?: The most recent disclosed round is a Series A, announced in September 2021.
Where is iECURE based?: iECURE is based in Philadelphia, Pennsylvania.
What sector does iECURE operate in?: iECURE is tracked under Biotech from Philadelphia, Pennsylvania, with $50M in disclosed funding.
When did iECURE last raise?: The last disclosed iECURE round closed in September 2021 at Series A.

Totals shown for iECURE aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Philadelphia and the investors behind them below.

iECURE Funding: $50M Raised, Series A (2021)

iECURE funding overview

iECURE at a glance

Frequently asked about iECURE funding

Companies related to iECURE (40)

Browse related funding lists (4)